News & Updates
Filter by Specialty:
![Lung function not affected in children, adolescents post-COVID](https://sitmspst.blob.core.windows.net/images/articles/lung-function-not-affected-in-children-adolescents-post-covid-ae86bb5a-c557-4ddd-b972-a6b7b516405c-square.jpg)
Lung function not affected in children, adolescents post-COVID
27 Sep 2021
byRoshini Claire Anthony
COVID-19 does not appear to result in long-term impairment of lung function in children and adolescents, according to two studies presented at ERS 2021.
Lung function not affected in children, adolescents post-COVID
27 Sep 2021![Olanzapine a favourable alternative to dexamethasone for CINV](https://sitmspst.blob.core.windows.net/images/articles/olanzapine-esmo-2021-bb1cb264-4c86-4c0e-8788-5308d9f1aca8-square.jpg)
Olanzapine a favourable alternative to dexamethasone for CINV
27 Sep 2021
byAudrey Abella
Olanzapine administered at a dose of 5 mg was noninferior to dexamethasone and is associated with fewer adverse effects than dexamethasone for chemotherapy-induced nausea and vomiting (CINV), according to data presented at ESMO 2021.
Olanzapine a favourable alternative to dexamethasone for CINV
27 Sep 2021![Ribociclib plus letrozole improves OS in hormone receptor–positive, HER2-negative advanced breast cancer](https://sitmspst.blob.core.windows.net/images/articles/ribo-da6bf1ef-e929-4a1a-9205-c6927908f0ea-square.jpg)
Ribociclib plus letrozole improves OS in hormone receptor–positive, HER2-negative advanced breast cancer
27 Sep 2021
byDr Margaret Shi
A combined regimen of ribociclib plus letrozole as first-line treatment provides a statistically significant and clinically meaningful overall survival (OS) benefit vs placebo plus letrozole in postmenopausal patients with hormone receptor–positive and HER2-negative advanced breast cancer (BC), results of the phase III MONALEESA-2 study have shown.